Latest Insider Transactions at Alteryx, Inc. (AYX)
This section provides a real-time view of insider transactions for Alteryx, Inc. (AYX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alteryx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alteryx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 05
2022
|
Mark Anderson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,320
+26.25%
|
-
|
Jun 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,148
-1.85%
|
$118,140
$55.92 P/Share
|
Jun 01
2022
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,879
-10.51%
|
$708,345
$55.92 P/Share
|
Jun 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.51%
|
$63,030
$55.92 P/Share
|
Jun 01
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,139
-3.42%
|
$282,645
$55.92 P/Share
|
May 25
2022
|
Jeff Horing |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+37.59%
|
-
|
May 25
2022
|
Timothy I Maudlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+8.11%
|
-
|
May 25
2022
|
Eileen Schloss Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+24.46%
|
-
|
May 25
2022
|
Ce Celia Morken Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+24.35%
|
-
|
May 25
2022
|
Daniel J Warmenhoven Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+24.35%
|
-
|
May 25
2022
|
Charles Cory Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+27.89%
|
-
|
May 25
2022
|
Anjali Joshi Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+28.75%
|
-
|
May 25
2022
|
Dean Stoecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,632
+4.24%
|
-
|
May 13
2022
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,053
-1.33%
|
$61,074
$58.83 P/Share
|
May 04
2022
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,445
-21.5%
|
$1,781,150
$70.63 P/Share
|
May 04
2022
|
Mark Anderson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,321
+30.25%
|
-
|
May 04
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,054
-2.56%
|
$213,780
$70.63 P/Share
|
May 04
2022
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+4.91%
|
-
|
May 04
2022
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,998
-3.16%
|
$279,860
$70.63 P/Share
|
May 04
2022
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
9,580
+7.04%
|
-
|
May 04
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,715
-3.46%
|
$190,050
$70.63 P/Share
|
May 04
2022
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,474
+6.51%
|
-
|
May 04
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,249
-2.75%
|
$297,430
$70.63 P/Share
|
May 04
2022
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,580
+5.84%
|
-
|
Mar 11
2022
|
Dean Stoecker Director |
SELL
Open market or private sale
|
Indirect |
20,000
-84.48%
|
$1,240,000
$62.62 P/Share
|
Mar 10
2022
|
Dean Stoecker Director |
BUY
Bona fide gift
|
Indirect |
20,000
+50.0%
|
-
|
Mar 10
2022
|
Dean Stoecker Director |
SELL
Bona fide gift
|
Indirect |
24,300
-58.85%
|
-
|
Mar 07
2022
|
Dean Stoecker Director |
BUY
Conversion of derivative security
|
Indirect |
24,300
+50.0%
|
-
|
Mar 07
2022
|
Alteryx, Inc. Director |
BUY
Conversion of derivative security
|
Indirect |
24,300
+50.0%
|
-
|
Mar 01
2022
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,360
-11.09%
|
$526,680
$63.21 P/Share
|
Mar 01
2022
|
Scott Davidson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,280
-6.46%
|
$143,640
$63.21 P/Share
|
Mar 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,993
-5.03%
|
$377,559
$63.21 P/Share
|
Mar 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,090
-2.78%
|
$131,670
$63.21 P/Share
|
Mar 01
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-2.9%
|
$272,475
$63.21 P/Share
|
Feb 25
2022
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+25.83%
|
-
|
Feb 25
2022
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
27,722
+26.94%
|
-
|
Feb 25
2022
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+30.39%
|
-
|
Feb 25
2022
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+30.78%
|
-
|
Feb 24
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
56,829
+1.26%
|
$3,125,595
$55.44 P/Share
|
Feb 23
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
534,399
+19.03%
|
$29,391,945
$55.08 P/Share
|
Feb 22
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
320,601
+31.59%
|
$17,312,454
$54.88 P/Share
|
Feb 18
2022
|
Timothy I Maudlin Director |
SELL
Open market or private sale
|
Direct |
9,233
-9.95%
|
$517,048
$56.07 P/Share
|
Feb 18
2022
|
Timothy I Maudlin Director |
BUY
Conversion of derivative security
|
Direct |
43,000
+47.9%
|
-
|
Feb 07
2022
|
Chris Natali Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,195
+50.0%
|
-
|
Jan 01
2022
|
Scott Davidson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,767
-9.64%
|
$226,020
$60.5 P/Share
|
Jan 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-6.15%
|
$185,220
$60.5 P/Share
|
Jan 01
2022
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,056
-15.04%
|
$843,360
$60.5 P/Share
|
Jan 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,228
-8.54%
|
$373,680
$60.5 P/Share
|
Dec 08
2021
|
Dean Stoecker Director |
SELL
Open market or private sale
|
Indirect |
2,500
-65.04%
|
$165,000
$66.53 P/Share
|
Dec 07
2021
|
Dean Stoecker Director |
SELL
Open market or private sale
|
Indirect |
2,500
-26.7%
|
$165,000
$66.1 P/Share
|